PUBMED FOR HANDHELDS

Journal Abstract Search


238 related items for PubMed ID: 12593526

  • 1. Comparison of the efficacy of beclometasone dipropionate and fluticasone propionate suspensions for nebulization in adult patients with persistent asthma.
    Terzano C, Ricci A, Burinschi V, Nekam K, Lahovsky J.
    Respir Med; 2003 Feb; 97 Suppl B():S35-40. PubMed ID: 12593526
    [Abstract] [Full Text] [Related]

  • 2. Comparison of the efficacy and safety of high doses of beclometasone dipropionate suspension for nebulization and beclometasone dipropionate via a metered-dose inhaler in steroid-dependent adults with moderate to severe asthma.
    Grzelewska-Rzymowska I, Kroczynska-Bednarek J, Zarkovic J.
    Respir Med; 2003 Feb; 97 Suppl B():S21-6. PubMed ID: 12593524
    [Abstract] [Full Text] [Related]

  • 3. Comparison of the efficacy and safety of beclometasone dipropionate suspension for nebulization and beclometasone dipropionate via a metered-dose inhaler in paediatric patients with moderate to severe exacerbation of asthma.
    Bisca N, Cernatescu I, Dragomir D, Iacomi A, Mirceau M, Orascanu D.
    Respir Med; 2003 Feb; 97 Suppl B():S15-20. PubMed ID: 12593523
    [Abstract] [Full Text] [Related]

  • 4. Efficacy of HFA-beclomethasone dipropionate extra-fine aerosol (800 microg day(-1)) versus HFA-fluticasone propionate (1000 microg day(-1)) in patients with asthma.
    Aubier M, Wettenger R, Gans SJ.
    Respir Med; 2001 Mar; 95(3):212-20. PubMed ID: 11266239
    [Abstract] [Full Text] [Related]

  • 5. The response of two different dosages of beclometasone dipropionate suspension for nebulization versus a standard dose of beclometasone dipropionate via a metered-dose inhaler on bronchoprovocation testing in adults with asthma.
    Bousquet J, Meziane H, Chanez P, Mueser M, Umile A.
    Respir Med; 2003 Feb; 97 Suppl B():S11-4. PubMed ID: 12593522
    [Abstract] [Full Text] [Related]

  • 6. Efficacy and tolerability of fluticasone propionate/salmeterol administered twice daily via hydrofluoroalkane 134a metered-dose inhaler in adolescent and adult patients with persistent asthma: a randomized, double-blind, placebo-controlled, 12-week study.
    Nathan RA, Rooklin A, Schoaf L, Scott C, Ellsworth A, House K, Dorinsky P.
    Clin Ther; 2006 Jan; 28(1):73-85. PubMed ID: 16490581
    [Abstract] [Full Text] [Related]

  • 7. Fluticasone propionate 1 mg daily and beclomethasone dipropionate 2 mg daily: a comparison over 1 yr.
    Lorentzen KA, Van Helmond JL, Bauer K, Langaker KE, Bonifazi F, Harris TA.
    Respir Med; 1996 Nov; 90(10):609-17. PubMed ID: 8959118
    [Abstract] [Full Text] [Related]

  • 8. A randomized, double-blind comparison of beclomethasone dipropionate extrafine aerosol and fluticasone propionate.
    Fairfax A, Hall I, Spelman R.
    Ann Allergy Asthma Immunol; 2001 May; 86(5):575-82. PubMed ID: 11379810
    [Abstract] [Full Text] [Related]

  • 9. Diskus and diskhaler: efficacy and safety of fluticasone propionate via two dry powder inhalers in subjects with mild-to-moderate persistent asthma.
    Galant SP, van Bavel J, Finn A, Gross G, Pleskow W, Brown A, Hamedani AG, Harding SM.
    Ann Allergy Asthma Immunol; 1999 Mar; 82(3):273-80. PubMed ID: 10094218
    [Abstract] [Full Text] [Related]

  • 10. Comparison of the efficacy and safety of inhaled fluticasone propionate 200 micrograms/day with inhaled beclomethasone dipropionate 400 micrograms/day in mild and moderate asthma.
    Gustafsson P, Tsanakas J, Gold M, Primhak R, Radford M, Gillies E.
    Arch Dis Child; 1993 Aug; 69(2):206-11. PubMed ID: 8215522
    [Abstract] [Full Text] [Related]

  • 11. Evaluation of fluticasone propionate (500 micrograms day-1) administered either as dry powder via a Diskhaler inhaler or pressurized inhaler and compared with beclomethasone dipropionate (1000 micrograms day-1) administered by pressurized inhaler.
    Lundback B, Alexander M, Day J, Hebert J, Holzer R, Van Uffelen R, Kesten S, Jones AL.
    Respir Med; 1993 Nov; 87(8):609-20. PubMed ID: 8290745
    [Abstract] [Full Text] [Related]

  • 12. A comparison of fluticasone propionate, 1 mg daily, with beclomethasone dipropionate, 2 mg daily, in the treatment of severe asthma. International Study Group.
    Barnes NC, Marone G, Di Maria GU, Visser S, Utama I, Payne SL.
    Eur Respir J; 1993 Jun; 6(6):877-85. PubMed ID: 8339809
    [Abstract] [Full Text] [Related]

  • 13. Comparison of the efficacy and safety of nebulized beclometasone dipropionate and budesonide in severe persistent childhood asthma.
    Delacourt C, Dutau G, Lefrançois G, Clerson P, Beclospin Clinical Development Group.
    Respir Med; 2003 Feb; 97 Suppl B():S27-33. PubMed ID: 12593525
    [Abstract] [Full Text] [Related]

  • 14. Extrafine beclomethasone dipropionate breath-actuated inhaler (400 micrograms/day) versus budesonide dry powder inhaler (800 micrograms/day) in asthma.
    Reichel W, Dahl R, Ringdal N, Zetterstrom O, van den Elshout FJ, Laitinen LA.
    Int J Clin Pract; 2001 Mar; 55(2):100-6. PubMed ID: 11321849
    [Abstract] [Full Text] [Related]

  • 15. Beclomethasone dipropionate versus budesonide inhalation suspension in children with mild to moderate persistent asthma.
    Terzano C, Allegra L, Barkai L, Cremonesi G.
    Eur Rev Med Pharmacol Sci; 2001 Mar; 5(1):17-24. PubMed ID: 11860218
    [Abstract] [Full Text] [Related]

  • 16. Comparison of the bioavailability and systemic effects of beclometasone dipropionate suspension for nebulization and beclometasone dipropionate via a metered-dose inhaler after single-dose administration in healthy male volunteers.
    Poli G, Acerbi D.
    Respir Med; 2003 Feb; 97 Suppl B():S5-9. PubMed ID: 12593521
    [Abstract] [Full Text] [Related]

  • 17. Long-term efficacy and safety of fluticasone propionate powder administered once or twice daily via inhaler to patients with moderate asthma.
    ZuWallack R, Adelglass J, Clifford DP, Duke SP, Wire PD, Faris M, Harding SM.
    Chest; 2000 Aug; 118(2):303-12. PubMed ID: 10936117
    [Abstract] [Full Text] [Related]

  • 18. Efficacy and safety of a 12-week therapy with a new formulation of fluticasone propionate at doses of 125 and 250 μg administered through a new generation cyclohaler twice daily, in comparison to fluticasone propionate 500 μg dry powder inhaler twice daily in patients with moderate asthma.
    Kupryś-Lipińska I, Tworek D, Vanderbist F, Bocheńska-Marciniak M, Kuna P.
    Pneumonol Alergol Pol; 2013 Aug; 81(6):527-36. PubMed ID: 24142782
    [Abstract] [Full Text] [Related]

  • 19. Short-Term Growth During Treatment with Inhaled Fluticasone Propionate/Formoterol, Fluticasone and Beclomethasone Treatment.
    Wolthers OD, Moore A, Mersmann S, Dissanayake S.
    J Aerosol Med Pulm Drug Deliv; 2017 Oct; 30(5):373-380. PubMed ID: 28510491
    [Abstract] [Full Text] [Related]

  • 20. Fluticasone propionate powder administered through Diskhaler versus triamcinolone acetonide aerosol administered through metered-dose inhaler in patients with persistent asthma.
    Condemi JJ, Chervinsky P, Goldstein MF, Ford LB, Berger WE, Ayars GH, Rogenes PR, Edwards L, Pepsin PJ.
    J Allergy Clin Immunol; 1997 Oct; 100(4):467-74. PubMed ID: 9338539
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 12.